Fig. 1

The prevalence of 14 PfCRT mutations, 15 K13 mutations, and CNVs of plasmepsin 2/3 in different border regions. CRT mutations associated with CQ and PPQ resistance and K13 mutations associated with ART resistance are displayed in different dashed boxes. CM China–Myanmar border (yellow circles), TM Thailand–Myanmar border (green circles), TC Thailand–Cambodia border (red circles)